通过疾病-蛋白质-药物网络,对与粉样体沉积相关的疾病进行综合网络分析
Aikaterini E I Rizou1, Georgia I Nasi1, Avgi E Apostolakou1
1Section of Cell Biology and Biophysics, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Panepistimiopolis, 15701 Athens, Greece.
Pharmaceuticals (Basel, Switzerland)
|January 8, 2025
概括
这项研究构建了粉样性粉症的疾病-蛋白质-药物网络,确定了疾病的共同点,并为粉样性沉积疾病提出了药物重用候选人.
科学领域:
- 系统生物学 系统生物学
- 网络分析 网络分析
- 药物基因组学 药物基因组学
背景情况:
- 高通量技术提高了对生物实体关联的理解.
- 相互作用网络对于可视化复杂的生物关系至关重要.
- 网络分析有助于提取新的生物知识.
研究的目的:
- 建立一个全面的疾病-蛋白质-药物网络.
- 专注于粉样粉症和其他粉样沉积疾病.
- 为了确定这些条件的潜在药物重用候选人.
主要方法:
- 建立了一个融合蛋白质-蛋白质,蛋白质-药物和疾病-药物协会的异质网络.
- 包括粉胺基蛋白和粉胺沉积物中共同沉积的蛋白质.
- 进行了基于疾病和基于药物的网络分析.
主要成果:
- 突出了不同类型的氨基粉症和相关疾病之间的共同点.
- 提出了一种已批准的药物,用于潜在的重新利用.
- 确定了新的疾病关联和候选药物.
结论:
- 这些发现建议进一步调查已识别的疾病关联.
- 拟议的候选药物需要进一步研究,以治疗粉样沉积疾病.
- 网络方法为了解和治疗复杂疾病提供了有价值的工具.
相关概念视频
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444


